Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-MarketGlobeNewsWire • 09/24/20
Conformis, Inc. to Present at the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech SummitGlobeNewsWire • 09/16/20
Conformis, Inc. to Participate in the 2020 Wells Fargo Virtual Healthcare ConferenceGlobeNewsWire • 09/02/20
Conformis Announces Achievement of Second Milestone Under Development and License AgreementsGlobeNewsWire • 08/20/20
Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants ReportedGlobeNewsWire • 08/13/20
90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee ReplacementsGlobeNewsWire • 08/10/20
Conformis' (CFMS) CEO Mark Augusti on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical CentersGlobeNewsWire • 08/05/20
ConforMIS (CFMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/22/20
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit AgreementGlobeNewsWire • 07/06/20
Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant DesignGlobeNewsWire • 05/21/20
Conformis (CFMS) CEO Mark Augusti on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/29/20
Conformis, Inc. (CFMS) CEO Mark Augusti on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/03/20
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United KingdomGlobeNewsWire • 02/19/20